Skip to main content

Table 3 Per protocol analysis of the primary endpoint

From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

  Per protocol (PP) evaluation
Group I Group II Group III Total p-value
< D75 15 23 20 58  
≥ D75 8 0 3 11 0.004*
Unknown NA NA NA NA  
Total 23 23 23 69  
  1. *Pearson Chi-Square Test (Exact-Sign).